Improvement in Cardiometabolic Risk Factors During Smoking Cessation Treatment in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
Hsin-Ju ChenWei-Hsin HuangHsin-Lung ChanLee-Ching HwangPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)
Participation in a smoking cessation program was associated with improvements in glycemic control and cardiometabolic risk factors in patients with type 2 diabetes. The observed improvements were associated with participation in the program but not with the decrease in smoking amount.